Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 June 2025 | Story Andre Damons | Photo Andre Damons
Prof Matlalepula Matsabisa
Prof Motlalepula Matsabisa, renowned African Traditional Medicine expert and pharmacology researcher from the University of the Free State (UFS) will co-chair the World Health Organisation Global Traditional Medicine Summit steering committee.

Prof Motlalepula Matsabisa, renowned African Traditional Medicine expert and pharmacology researcher from the University of the Free State (UFS) has recently been elected a co-chairperson of the World Health Organisation (WHO) Global Traditional Medicine Summit steering committee. The other co-chairperson is Dr Goh Cheng Soon from Malaysia. 

The steering committee, which is appointed for one year, will help the WHO to organise the WHO Traditional Medicines Global Summit taking place later this year in New Delhi, India. The steering committee is also an advisory body to the WHO and the Global Traditional Medicine Centre to provide reviews and recommendations for the WHO Traditional Medicine Global Summit coordination, propose summit sessions and session speakers. This committee has 15 members from South Africa, Malaysia, Saudi Arabia, Ghana, India, China, Bhutan, Germany, Brazil, Egypt, New Zealand, US, Netherlands, Switzerland and Bolivia.

Prof Matsabisa, Research Director of the African Medicines Innovations and Technologies Development (AMITD) platform at the UFS, is also the chairperson of the WHO Africa Regional Expert Advisory Committee on Traditional Medicine (REACT)

 

Responsibility of the committee 

“Once more this is an honour for me to take this task and lead a group of experts – not just from the African continent where I am currently the chairperson of the WHO Afro REACT committee, but now I chair experts from all the continents and all six WHO geographical regions – namely Africa (Afro), the Americas (AMRO), the eastern Mediterranean (EMRO), Europe (EURO), South East Asia (SEARO) and the Western Pacific (WPRO). I chair a worldwide group of experts,” says Prof Matsabisa. 

According to him, the committee will work with WHO to design the summit programme, identify summit sessions and session speakers, as well as recommend ministers to be in the round-table discussions. The committee will also be responsible for the design of the exhibitions that will showcase traditional medicine products and practices across all six WHO regions. The identification of the sessions will be around action and delivery on the priority agenda from the past 2023 WHO Global summit as well as from the deliverables of the WHO 2025-2034 Traditional Medicines strategy. 

The theme for the WHO Traditional Medicines Global Summit is “Restoring balance for people and planet. The science and practice of health and well-being”. They anticipate attracting 6 000 people, from all over, to attend the summit with at least 1 000 in-person attendees and another 5 000 online participants. 

The committee will look at the first WHO 2023 Traditional Medicines Global summit and its Gujarat Declaration where the Traditional Medicine (TM) priority agenda was set – this priority agenda included global leadership, research and evidence, universal health coverage (UHC), primary health care (PHC) health systems, data and routine information systems, biodiversity and sustainability.

 

Market the UFS 

When a call for applications to serve on the steering committee went out, Prof Matsabisa applied and was later approached by the WHO to chair the steering and advisory committee. “I see this as an opportunity to serve the WHO and use my knowledge and skills to serve the world. I felt very honoured to have been approached for such an important job and role to undertake. As a chairperson, I will guide the committee, take responsibility for the planning and implementation of the summit. I will market the summit. I shall be the direct link between the WHO in Geneva and the committee.”

Prof Matsabisa indicated that he will use the chairmanship to market and internationalise the UFS AMITD programme and give it a further global outlook. He will also find new collaborators and potential funders and investors for projects and activities of the UFS and secure activities that will help find and fund global postdoctoral fellows and visiting scholars. This will be good for the AMITD platform.

“The steering committee shall set the 2nd WHO Traditional Medicine Global Summit theme for scale up learning, collaboration and action,” says Prof Matsabisa. “Therefore, the committee will design the summit programme to address these and take themes and discussions from high-level political commitments, building on UNGA, WHA, G20, BRICS, and AU etc. Launches of the WHO Global TM Library on Traditional Medicine; WHO Bulletin special issue on Traditional Medicine; TM Innovation and Investment Initiative; Global TM Research Roadmap; Global TM Data Network; and Learnings from Indigenous Knowledge will also take place.”

Furthermore, advancements of healthy ecosystems and TM integration and encouraging indigenous people's knowledge exchange; and AI and TM governance course/ brief as well as the advancing of cross-cutting frameworks for TM-related ethics, rights, IP, equitable access and benefits are on the agenda. 

News Archive

Dr Charlotte Boucher and Lindi Heyns examine possible anti-microbial activity in the skin of Western olive toad species
2014-12-22

 

Researchers Lindi Heyns and Dr Charlotte Boucher are working together on an interdisciplinary project between the Departments of Zoology and Entomology and Veterinary Biotechnology at the University of the Free State (UFS). The focus of their research is on the preliminary biochemical description of skin secretions in some South African toads.

The project forms part of an Honours study executed by Dwayne Pike under Heyns’ supervision. He is co-supervised by Dr Boucher who is assisting with the biochemical and microbiological assays.

Dr Boucher said, “Amphibians are characterised by the presence of cutaneous glands spread over the skin. There are two types of glands, namely mucous and granular (poison), located on the inner surface of the epidermis. Mucous glands are widely dispersed over the skin, while granular glands can be grouped and enlarged in specific regions. Mucous glands are generally associated with maintenance of humidity and cutaneous respiration, whereas granular glands function in chemical defence against predators and/or microbial infection. Studies indicate that the compounds produced by the granular glands belong to numerous chemical classes with diverse pharmacological activities.”

The products secreted by granular glands are rich in low molecular weight constituents of varied molecular types, including proteins, peptides and toxins. These secretions make the toad foul-tasting to predators and even toxic to other frog species. In addition, amphibians offer an attractive source of novel antimicrobials. Studies indicate that as a response to inhabiting microorganism-rich environments they synthesise and secrete a diverse array of antimicrobial peptides (AMPs) as an innate form of defence. Extensive research by various other research groups has been carried out on antimicrobial peptides of the genus Rana; however, hardly any studies have investigated the antimicrobial activity of African frog species.

The focus of this preliminary project is to determine the protein composition of the glandular secretions of the Western olive toad (Amietophrynus poweri), using biochemical tests, such as SDS-PAGE also known as protein gel electrophoresis combined with mass-spectrometry used to identify unknown peptides and proteins. This will give us an overview of the composition of the glandular secretions. Furthermore, we are also looking at microbiological tests, which include assays that test for possible anti-microbial activity against various bacterial and fungal species.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept